Lilly Immergluck to Anti-Bacterial Agents
This is a "connection" page, showing publications Lilly Immergluck has written about Anti-Bacterial Agents.
Connection Strength
0.883
-
Immergluck LC, Jain S, Ray SM, Mayberry R, Satola S, Parker TC, Yuan K, Mohammed A, Jerris RC. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers. West J Emerg Med. 2017 Feb; 18(2):201-212.
Score: 0.458
-
Immergluck LC, Geng R, Li C, Edelson M, Lin X, Waller LA, Rust G, Xu J, Leong T, Baltrus P. Space-time trends of community-onset Staphylococcus aureus infections in children: a group-based trajectory modeling approach. Ann Epidemiol. 2023 06; 82:45-53.e1.
Score: 0.175
-
Immergluck LC, Leong T, Malhotra K, Parker TC, Ali F, Jerris RC, Rust GS. Geographic surveillance of community associated MRSA infections in children using electronic health record data. BMC Infect Dis. 2019 Feb 18; 19(1):170.
Score: 0.132
-
Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555.
Score: 0.118